Description
Your doctor may prescribe Tyzeka for the treatment of chronic hepatitis B disease. Hepatitis B is a viral infection of the liver. The disease is often chronic and can last for several years. Hepatitis B virus infects the liver and can cause liver damage over time.
Tyzeka works by incorporating into the genetic material of the hepatitis B virus. By doing so, it prevents viral replication and helps to slow the infections. By slowing viral replication, it gives the immune system the chance to fight the infecftion.
Fact Table |
Formula |
C10H14N2O5 |
License |
US FDA, EU EMA |
Bioavailability |
68% |
Legal status |
Rx-only |
Chemical Name |
Telbivudine |
Elimination half-life |
40 to 49 hours |
Dosage (Strength) |
600mg |
Pregnancy |
No Known Risk |
Brands |
Tyzeka, Sebivo |
Protein binding |
Low |
PubChem CID |
159269 |
MedlinePlus |
a607045 |
ChEBI |
63624 |
ATC code |
J05AF11 |
DrugBank |
DB01265 |
KEGG |
D06675 |
Routes of administration |
By mouth |
Directions
The usual dosage for adults is 600 mg by mouth once daily.
The dose may be adjusted for people with kidney problems.
Ingredients
The active ingredient in Tyzeka is telbivudine.
Interactions
Tell your doctor and pharmacist if you are taking any of the following drugs prior to starting Tyzeka:
- Cladribine
- Interferons
- Peginterferon Alfa-2a
Cautions
Tell your doctor if you have a history of lactic acidosis before you start this drug as it can increase the risk of developing this condition.
Do not stop taking this drug without first speaking with your doctor.
Tyzeka can increase the risk of myopathy and peripheral neuropathy. Speak with your doctor if you have a history of these conditions.
Side Effects
The most common side effects of this medication include:
- Abdominal distension
- Abdominal pain
- Arthralgia
- Back pain
- Cough
- Diarrhea
- Dizziness
- Dyspepsia
- Exacerbation of hepatitis B
- Fatigue
- Fever
- Headache
- Hepatomegaly
- Hyperbilirubinemia
- Hypoesthesia
- Increased amylase
- Increased creatine phosphokinase
- Increased serum ALT
- Increased serum AST
- Increased serum lipase
- Insomnia
- Lactic acidosis
- Liver steatosis
- Myalgia
- Myopathy
- Myositis
- Nausea
- Neutropenia
- Paresthesia
- Peripheral neuropathy
- Pharyngolaryngeal pain
- Pruritus
- Rhabdomyolysis
- Skin rash
- Thrombocytopenia
References
Telbivudine [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2013.
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 11622